about
Calprotectin--a novel marker of obesity.In vitro palmitate treatment of myotubes from postmenopausal women leads to ceramide accumulation, inflammation and affected insulin signaling.Progressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial.Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIVPlasma YKL-40: a BMI-independent marker of type 2 diabetes.Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin.Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in miceInsulin signaling in skeletal muscle of HIV-infected patients in response to endurance and strength training.Muscle specific miRNAs are induced by testosterone and independently upregulated by ageEffect of a 2-year home-based endurance training intervention on physiological function and PSA doubling time in prostate cancer patients.Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals.Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy.Menopause is associated with decreased whole body fat oxidation during exercise.Correction: Expression of Fibroblast Growth Factor-21 in Muscle Is Associated with Lipodystrophy, Insulin Resistance and Lipid Disturbances in Patients with HIVLow plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy.The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy.RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass.Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes.Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy.Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.Pre-training levels of testosterone and sex hormone-binding globulin are not correlated with training adaptations in fat mass and insulin sensitivity in healthy young men.Inhibition of Lipolysis Stimulates Peripheral Glucose Uptake but Has No Effect on Endogenous Glucose Production in HIV LipodystrophyAdipose tissue lipin expression levels distinguish HIV patients with and without lipodystrophyAdipose tissue expression of IL-18 and HIV-associated lipodystrophyAdipose Tissue Interleukin-18 mRNA and Plasma Interleukin-18: Effect of Obesity and Exercise*
P50
Q33510158-738408C6-B6C2-4344-95FE-8515E55FCDC1Q33855536-AEB95C61-42D0-4FDD-994F-11379B5E88B7Q33977589-28D1401A-4883-458A-BD2E-0F23D3527C36Q34637577-1C4EAA7D-9F38-49B3-B93F-DDEE5A132DD2Q36943769-200F33E3-D061-4DD5-B77B-0E9DB1E7135FQ37080092-03C6A9A6-2F82-4651-9563-9BE5B425FA7EQ37110553-CC80ABDA-840C-4631-9EC8-27D97412A391Q37328088-C3BF7F60-D232-4D35-9696-82539D787067Q37506689-C791524D-882F-43D9-B334-36F007834595Q40907943-79CF63B3-FE5B-4D8B-BB53-E482FB9FF164Q42224997-E1680728-AD7B-4360-9E73-F17FAB70D25CQ42259848-1BCC56D5-3509-4299-8DEA-102175DC1821Q42268420-8883987B-F18B-42E0-AB6E-374378B80CA6Q42591796-36011ECD-37A6-462B-8683-37DACCB56B7BQ44738362-E229086E-2E1D-4AEB-9145-FBB2E4EAEB06Q44851487-8B1E7BD4-FB45-4CF5-88B5-0539313D6D75Q45393567-6719914F-5D52-4C6A-8AA9-4CBCDE61E09DQ46122914-6DEFC6F9-BD6A-4001-B3C2-3A62EBDA9081Q46433459-7B02F9EB-5D20-4097-8E1D-0656645BC1C8Q46956147-B5E54C17-99F8-4AC9-8073-DEA2A843FF6FQ48226767-49B535FA-0E59-42BA-A150-704496694759Q48345277-873DEAB5-40D8-477A-BDF0-2D3058A37AF2Q51506989-F706B28B-52B2-4BA5-9E1A-C3A9936CE849Q53813109-8E40EDE4-CCAC-49FE-AF02-3FB943AF4E94Q55940961-0D929016-5B08-4E28-835D-F29AB90CA01AQ59326204-95AF5D55-FF66-448F-8945-7A63EE57EFB4Q59326241-690ABF96-3BCF-4CC0-8398-8EEF776D0F94Q61762737-FCABFDB8-EB4B-45FA-A533-E550ECB216BB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Birgitte Lindegaard
@ast
Birgitte Lindegaard
@en
Birgitte Lindegaard
@es
Birgitte Lindegaard
@nl
Birgitte Lindegaard
@sl
type
label
Birgitte Lindegaard
@ast
Birgitte Lindegaard
@en
Birgitte Lindegaard
@es
Birgitte Lindegaard
@nl
Birgitte Lindegaard
@sl
prefLabel
Birgitte Lindegaard
@ast
Birgitte Lindegaard
@en
Birgitte Lindegaard
@es
Birgitte Lindegaard
@nl
Birgitte Lindegaard
@sl
P106
P21
P31
P496
0000-0002-5236-8427